Spontaneously Regressing Oral Papillomas Induce Systemic Antibodies That Neutralize Canine Oral Papillomavirus

This publication has 12 references indexed in Scilit:

• Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
  Proceedings of the National Academy of Sciences, 1995
• Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical Neoplasia
  The Journal of Infectious Diseases, 1995
• Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection
  Journal of Medical Virology, 1995
• Serum IgG, IgM, and IgA Reactivity to Human Papillomavirus Types 11 and 6 Virus-like Particles in Different Gynecologic Patient Groups
  The Journal of Infectious Diseases, 1995
• Use of Human Papillomavirus Type 6 Capsids to Detect Antibodies in People with Genital Warts
  The Journal of Infectious Diseases, 1995
• Serologic Response to Human Papillomavirus Type 16 (HPV-16) Virus-like Particles in HPV-16 DNA-Positive Invasive Cervical Cancer and Cervical Intraepithelial Neoplasia Grade III Patients and Controls from Colombia and Spain
  The Journal of Infectious Diseases, 1995
• Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus
  Journal of Clinical Microbiology, 1995
• Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera
  Journal of General Virology, 1994
• A Formalin-Inactivated Vaccine Protects against Mucosal Papillomavirus Infection: A Canine Model
  Pathobiology, 1994
• Comparison of neutralization of BPV‐1 infection of C127 cells and bovine fetal skin xenografts
  International Journal of Cancer, 1991